Every 8-K that Align Technology Inc (ALGN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ALGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALGN filings page.
Align Technology, Inc. (ALGN) announced that its Board of Directors appointed Quentin Blackford, President and CEO of iRhythm Technologies, as a director effective August 27, 2026, increasing the Board size from ten to eleven directors. He is expected to stand for election at the May 2027 annual meeting and will receive prorated non-employee director compensation under Align’s existing program, along with a standard director indemnification agreement.
Andrea L. Saia notified the Board that she will retire as a director effective September 23, 2026; her decision is stated not to result from any disagreement with Align on operations, policies or practices. Upon her resignation, the Board size will automatically decrease back to ten directors. Align highlights its scale with over 302.0 thousand doctor customers and approximately 23.5 million Invisalign patients treated within a 600 million consumer market opportunity.
Align Technology, Inc. announced a set of governance, strategic, and capital-allocation initiatives intended to support long-term growth and shareholder value. Following discussions with Elliott Investment Management, the company plans to appoint three new independent directors to its Board, focusing on candidates with healthcare, medical device, technology, and global operations experience.
Align has begun a comprehensive strategic and operating model review with a global consulting firm, aimed at strengthening commercial execution, organizational effectiveness, resource optimization, and scalability, with the goal of supporting sustainable revenue growth and margin expansion. The company increased its 2026 share repurchase commitment and now intends to repurchase $400 million to $500 million of common stock during 2026. Align reports over 302.0 thousand doctor customers, a 600 million consumer market opportunity, and approximately 23.5 million patients treated with Invisalign over 29 years.
Align Technology reported record Q2 2026 revenue of $1,056.2 million, up 4.3% year-over-year and 1.5% sequentially. Clear Aligner revenue was $870.9 million, up 8.2% year-over-year on record shipments of 691.8 thousand cases, while Imaging Systems and CAD/CAM Services revenue was $185.3 million, down 10.8% year-over-year.
GAAP gross margin was 71.7% and operating margin 14.6%; on a non-GAAP basis, gross margin was 72.3% and operating margin 22.9%. GAAP net income was $108.3 million, or $1.51 per diluted share, and non-GAAP diluted EPS was $2.64. Cash and cash equivalents were $1,102.6 million, with six‑month operating cash flow of $343.8 million. The company repurchased about 393.4 thousand shares for approximately $67 million and plans total 2026 repurchases of $400–$500 million. Align recorded an estimated $37.5 million UK VAT liability and will begin charging 20% UK VAT on applicable products from September 7, 2026. Management expects Q3 2026 revenue of $1.00–$1.02 billion and continues to target 3–4% full‑year 2026 revenue growth with higher GAAP and non-GAAP operating margins versus 2025.
Align Technology, Inc. reported that Julie Coletti, its Executive Vice President and Chief Legal and Regulatory Officer, has resigned to join Illumina, Inc. as Chief Legal Officer. The company states that her resignation was submitted on July 6, 2026 and will be effective August 1, 2026.
The filing does not describe any dispute or disagreement, indicating the change is related to Ms. Coletti’s decision to take a new role at another company.
Align Technology, Inc. announced a planned Board leadership transition. C. Raymond Larkin, Jr. will retire as Chairman of the Board effective July 1, 2026, after more than 20 years of service, and will remain on the Board and the Nominating and Governance Committee through December 31, 2026. His decision to step down from the Board is stated as not due to any disagreement with the company’s operations, policies, or practices.
The Board has appointed Kevin Conroy, an independent director since December 2023 and Chair of the Compensation and Human Capital Committee since January 2026, to become Chairman effective July 1, 2026. The company highlights his prior leadership at Exact Sciences and ongoing board role at Abbott Laboratories as relevant experience for Align’s next phase of growth and innovation in digital dentistry.
Align Technology reported the results of its 2026 Annual Meeting of Stockholders. Shareholders elected all ten director nominees, with support levels generally around 56.7–59.0 million shares voted "For" each candidate and 4,807,543 broker non-votes recorded on each director proposal.
Stockholders approved, on an advisory basis, the compensation of the named executive officers, with 53,008,355 votes "For", 6,285,144 "Against" and 58,546 "Abstain", plus 4,807,543 broker non-votes. They also ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, by 61,733,668 votes "For", 2,374,738 "Against" and 51,182 "Abstain".
In addition, stockholders ratified the special meeting provision in the Company’s Amended and Restated Bylaws, with 43,694,385 votes "For", 15,598,140 "Against" and 59,522 "Abstain", along with 4,807,543 broker non-votes.
Align Technology, Inc. plans to repurchase $200.0 million of its common stock through open market transactions under its previously approved $1.0 billion stock repurchase program. The purchases will be made under a Rule 10b5-1 trading plan and funded with existing cash.
The repurchases are expected to be completed by October 2026. As of March 31, 2026, Align had approximately 71.6 million shares outstanding and $1,059.8 million in cash and cash equivalents, including $206.6 million held domestically to support the latest trading plan.
Align Technology reported solid first quarter 2026 results with growth in clear aligners and reaffirmed its full‑year outlook. Q1’26 net revenues were $1,040.1 million, up 6.2% year-over-year, driven mainly by Clear Aligner revenues of $856.0 million and record Invisalign shipments of 685.7 thousand cases.
GAAP gross margin was 70.8% and GAAP operating margin was 13.6%, while non‑GAAP gross and operating margins were 71.8% and 21.5%, respectively. GAAP diluted EPS was $1.57 and non‑GAAP diluted EPS was $2.58. The company completed a previously announced $200 million repurchase and plans to repurchase up to another $200 million of stock while reaffirming 2026 revenue growth guidance of 3% to 4% year-over-year.
Align Technology, Inc. updated its corporate bylaws after board approval on February 24, 2026. The amended and restated bylaws now require the board to call a special stockholder meeting if one or more stockholders properly request it and have continuously held at least 25% of the company’s outstanding common stock for at least one year before mailing the request.
The bylaws also add informational, timing, and other procedural requirements for such requests, and include additional clarifying, conforming, technical, and ministerial changes. The full amended bylaws are attached as an exhibit.
Align Technology, Inc. furnished an update saying it has issued a press release and will hold a conference call covering its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The press release is provided as Exhibit 99.1 and is treated as furnished, not filed, under securities law.
Align Technology furnished an 8-K under Item 2.02 announcing it issued a press release and will hold a conference call regarding its financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1, and a Cover Page Interactive Data File is embedded as Exhibit 104. The company notes this information is being furnished, not filed, under the Exchange Act.
Align Technology, Inc. disclosed that it has terminated the employment of Mr. Stuart Hockridge, its Executive Vice President, Global Human Resources, with the termination effective in May 2026. The company states that the termination is not for “cause” under his May 23, 2016 employment agreement. Any severance, compensation, or benefits he receives will be materially consistent with that agreement and with the disclosures under “Termination Unrelated to a Change of Control” in Align’s 2025 proxy statement filed on April 8, 2025.